Article
Efficacy of 300 IR house dust mite immunotherapy as a function of disease activity: Tertile analysis in clinical trials
28 Mar 2024
Abstract excerpt
BACKGROUND: The symptoms of house dust mite (HDM)-induced allergic rhinitis (AR) vary with changes in exposure related to the weather or the domestic environment. In allergen immunotherapy (AIT) studies, a certain level of AR disease activity is necessary to demonstrate treatment efficacy; the latter can be underestimated if a substantial proportion of the patient population is weakly symptomatic. OBJECTIVE: To...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
